• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有皮肤受累的母细胞性自然杀伤/结外自然杀伤样T细胞淋巴瘤的基因组改变。

Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.

作者信息

Mao Xin, Onadim Zerrin, Price Elizabeth A, Child Fiona, Lillington Debra M, Russell-Jones Robin, Young Bryan D, Whittaker Sean

机构信息

Skin Tumour Unit, St John's Institute of Dermatology, 4th Floor, South Wing Block 7, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.

出版信息

J Invest Dermatol. 2003 Sep;121(3):618-27. doi: 10.1046/j.1523-1747.2003.12406.x.

DOI:10.1046/j.1523-1747.2003.12406.x
PMID:12925224
Abstract

Natural killer and natural killer-like T cell lymphomas represent a rare type of non-Hodgkin's lymphoma originally described to involve the upper aerodigestive tract. This malignancy has been increasingly observed in other extranodal sites, particularly in the skin. Patients with cutaneous natural killer cell lymphoma generally have a poor prognosis; however, the etiology and the underlying molecular pathogenesis remain unclear. This study aimed to investigate comprehensively genomic changes in blastic natural killer and extranodal natural killer-like T cell lymphoma with cutaneous involvement. Comparative genomic hybridization showed chromosome imbalances in six of eight cases studied (75%). The mean number of chromosome imbalances per sample was 2.18+/-1.63 with similar number of gains (1.18+/-1.17) and losses (1.00+/-1.34). The most frequent DNA copy number changes observed were losses of 9/9p (83%), followed by loss of 13q and gain of 7 (67%). Similar patterns of chromosome imbalances were observed in both blastic natural killer and cutaneous natural killer-like T cell lymphomas. Loss of the RB1 gene at 13q14.2 was detected in one blastic natural killer cell lymphoma with 13q loss using a gene dosage assay, and in one cutaneous natural killer-like T cell lymphoma without 13q loss using fluorescent in situ hybridization. Genomic microarray analysis identified oncogene copy number gains of PAK1 and JUNB in three of four cases studied, and gains of RAF1, CTSB, FGFR1, and BCR in two cases. Real-time polymerase chain reaction detected amplification of CTSB and RAF1 in four of five cases analyzed, JUNB and MYCN in three cases, and REL and YES1 in two cases, respectively. In conjunction with this study, an extensive literature search for the published G-banded karyotypes of four subsets of natural killer cell lymphomas was conducted, which showed a nonrandom pattern of multiple chromosome aberrations. These results reveal consistent genetic alterations in cutaneous natural killer cell lymphomas, and provide a basis for further investigation of molecular pathogenesis in this malignancy.

摘要

自然杀伤细胞和自然杀伤样T细胞淋巴瘤是一种罕见的非霍奇金淋巴瘤,最初被描述为累及上呼吸道消化道。这种恶性肿瘤在其他结外部位越来越多地被观察到,尤其是在皮肤。皮肤自然杀伤细胞淋巴瘤患者的预后通常较差;然而,其病因和潜在的分子发病机制仍不清楚。本研究旨在全面调查累及皮肤的母细胞性自然杀伤细胞和结外自然杀伤样T细胞淋巴瘤的基因组变化。比较基因组杂交显示,在所研究的8例病例中有6例(75%)存在染色体不平衡。每个样本的染色体不平衡平均数为2.18±1.63,增益(1.18±1.17)和缺失(1.00±1.34)数量相似。观察到的最常见的DNA拷贝数变化是9/9p缺失(83%),其次是13q缺失和7号染色体增益(67%)。在母细胞性自然杀伤细胞淋巴瘤和皮肤自然杀伤样T细胞淋巴瘤中观察到相似的染色体不平衡模式。使用基因剂量分析在1例有13q缺失的母细胞性自然杀伤细胞淋巴瘤中检测到13q14.2处RB1基因缺失,使用荧光原位杂交在1例无13q缺失的皮肤自然杀伤样T细胞淋巴瘤中检测到该缺失。基因组微阵列分析在4例研究病例中有3例鉴定出PAK1和JUNB的癌基因拷贝数增加,2例鉴定出RAF1、CTSB、FGFR1和BCR增加。实时聚合酶链反应分别在5例分析病例中有4例检测到CTSB和RAF1扩增,3例检测到JUNB和MYCN扩增,2例检测到REL和YES1扩增。结合本研究,对已发表的自然杀伤细胞淋巴瘤四个亚组的G带核型进行了广泛的文献检索,结果显示存在多染色体畸变的非随机模式。这些结果揭示了皮肤自然杀伤细胞淋巴瘤中一致的基因改变,并为进一步研究这种恶性肿瘤的分子发病机制提供了基础。

相似文献

1
Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.伴有皮肤受累的母细胞性自然杀伤/结外自然杀伤样T细胞淋巴瘤的基因组改变。
J Invest Dermatol. 2003 Sep;121(3):618-27. doi: 10.1046/j.1523-1747.2003.12406.x.
2
Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.原发性皮肤CD30+间变性大细胞淋巴瘤中的基因改变。
Genes Chromosomes Cancer. 2003 Jun;37(2):176-85. doi: 10.1002/gcc.10184.
3
Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.自然杀伤细胞淋巴瘤/白血病的比较基因组杂交分析。对基因改变一致模式的识别。
Am J Pathol. 1999 Nov;155(5):1419-25. doi: 10.1016/S0002-9440(10)65454-5.
4
T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.累及眼及眼附属器组织的T细胞和T/自然杀伤细胞淋巴瘤:7例临床病理、免疫组化及分子研究
Ophthalmology. 1999 Nov;106(11):2109-20. doi: 10.1016/S0161-6420(99)90492-X.
5
Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.皮肤原发性母细胞性自然杀伤细胞及结外自然杀伤细胞样T细胞淋巴瘤:来自英国的6例报告
Br J Dermatol. 2003 Mar;148(3):507-15. doi: 10.1046/j.1365-2133.2003.05227.x.
6
Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.原发性皮肤B细胞淋巴瘤的比较基因组杂交分析:疾病发病机制中常见基因组改变的鉴定
Genes Chromosomes Cancer. 2002 Oct;35(2):144-55. doi: 10.1002/gcc.10104.
7
BCL2 and JUNB abnormalities in primary cutaneous lymphomas.原发性皮肤淋巴瘤中的BCL2和JUNB异常。
Br J Dermatol. 2004 Sep;151(3):546-56. doi: 10.1111/j.1365-2133.2004.06106.x.
8
Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.自然杀伤细胞淋巴瘤/白血病的全基因组阵列比较基因组杂交:侵袭性NK细胞白血病和鼻型结外NK/T细胞淋巴瘤的不同基因组改变模式
Genes Chromosomes Cancer. 2005 Nov;44(3):247-55. doi: 10.1002/gcc.20245.
9
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.JUNB的扩增和过表达与原发性皮肤T细胞淋巴瘤相关。
Blood. 2003 Feb 15;101(4):1513-9. doi: 10.1182/blood-2002-08-2434. Epub 2002 Oct 3.
10
Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma.鼻型NK/T细胞淋巴瘤的比较基因组杂交研究
Cytometry. 2001 Apr 15;46(2):85-91. doi: 10.1002/cyto.1069.

引用本文的文献

1
Pak2 regulates myeloid-derived suppressor cell development in mice.Pak2调节小鼠骨髓来源的抑制性细胞的发育。
Blood Adv. 2017 Oct 10;1(22):1923-1933. doi: 10.1182/bloodadvances.2017007435.
2
Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.淋巴肿瘤中激活蛋白-1(AP-1)家族成员的表达模式。
Clin Exp Med. 2017 Aug;17(3):291-304. doi: 10.1007/s10238-016-0436-z. Epub 2016 Sep 6.
3
Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.PAK-1的过表达是结直肠癌疾病复发的一个独立预测指标。
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15895-902. eCollection 2015.
4
PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.PAK1是急性髓系白血病和骨髓增生异常综合征的一个治疗靶点。
Blood. 2015 Aug 27;126(9):1118-27. doi: 10.1182/blood-2014-12-618801. Epub 2015 Jul 13.
5
Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiation.Pak2调节造血祖细胞的增殖、存活和分化。
Stem Cells. 2015 May;33(5):1630-41. doi: 10.1002/stem.1951.
6
PAK signaling in cancer.癌症中的PAK信号传导
Cell Logist. 2012 Apr 1;2(2):105-116. doi: 10.4161/cl.21882.
7
The c-Rel Transcription Factor in Development and Disease.发育与疾病中的c-Rel转录因子
Genes Cancer. 2011 Jul;2(7):695-711. doi: 10.1177/1947601911421925.
8
PAK1 as a therapeutic target.PAK1 作为治疗靶点。
Expert Opin Ther Targets. 2010 Jul;14(7):703-25. doi: 10.1517/14728222.2010.492779.
9
Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.NUP98-DDX10 癌基因对原代人 CD34+ 细胞的影响:保守解旋酶基序的作用。
Leukemia. 2010 May;24(5):1001-11. doi: 10.1038/leu.2010.42. Epub 2010 Mar 25.
10
Pak protein kinases and their role in cancer.Pak蛋白激酶及其在癌症中的作用。
Cancer Metastasis Rev. 2009 Jun;28(1-2):51-63. doi: 10.1007/s10555-008-9168-1.